1. First Successful LVAD Implantation After BioVentrix Revivent TC Ventricular Reshaping.
- Author
-
Agdamag AC, Shaffer A, John R, Wechsler AS, Pritzker M, Fraser M, Martin CM, Cogswell R, and Alexy T
- Subjects
- Aged, Echocardiography, Heart Failure diagnosis, Heart Failure physiopathology, Heart Ventricles physiopathology, Humans, Male, Quality of Life, Tomography, X-Ray Computed, Cardiac Surgical Procedures methods, Heart Failure surgery, Heart Ventricles surgery, Heart-Assist Devices, Ventricular Function, Left physiology, Ventricular Remodeling physiology
- Abstract
The Revivent TC System (BioVentrix Inc, San Ramon, CA) enables a less invasive approach for left ventricular reshaping and scar exclusion in selected patients with ischemic cardiomyopathy. Although the system is designed to improve quality of life and to promote reverse remodeling, patients can still progress to end-stage heart failure requiring advanced therapies. This report describes a case of left ventricular assist device surgery in a patient 16 months after Revivent System implantation. The planning process and surgical technique proved to be complex. This case report can help provide guidance to advanced heart failure teams who encounter patients with the Revivent System who require left ventricular assist device support., (Copyright © 2021 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF